Natasa Miskov-Zivanov

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Pluripotent Stem Cells

Transcription Factor

Top Venues

ACS synthetic biology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Emilee Holtzapple, Gaoxiang Zhou, Haomiao Luo, Difei Tang, Niloofar Arazkhani, Casey Hansen, Cheryl A Telmer, Natasa Miskov-Zivanov
The BioRECIPE Knowledge Representation Format. ACS synthetic biology 13 (8) (2024)
Emilee Holtzapple, Gaoxiang Zhou, Haomiao Luo, Difei Tang, Niloofar Arazkhani, Casey Hansen, Cheryl A Telmer, Natasa Miskov-Zivanov
The BioRECIPE Knowledge Representation Format. ACS synthetic biology (2024)
Emilee Holtzapple, Gaoxiang Zhou, Haomiao Luo, Difei Tang, Niloofar Arazkhani, Casey Hansen, Cheryl A Telmer, Natasa Miskov-Zivanov
The BioRECIPE Knowledge Representation Format. ACS synthetic biology 13 (8) (2024)
Emilee Holtzapple, Gaoxiang Zhou, Haomiao Luo, Difei Tang, Niloofar Arazkhani, Casey Hansen, Cheryl A Telmer, Natasa Miskov-Zivanov
The BioRECIPE Knowledge Representation Format. ACS synthetic biology 13 (8) (2024)
Elisa Ruffo, Adam A Butchy, Yaniv Tivon, Victor So, Michael Kvorjak, Avani B Parikh, Eric L Adams, Natasa Miskov-Zivanov, Olivera J Finn, Alexander Deiters, Jason Lohmueller
Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting. Nature communications 14 (1) (2023)
Elisa Ruffo, Adam A Butchy, Yaniv Tivon, Victor So, Michael Kvorjak, Avani B Parikh, Eric L Adams, Natasa Miskov-Zivanov, Olivera J Finn, Alexander Deiters, Jason Lohmueller
Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting. Nature communications 14 (1) (2023)
Elisa Ruffo, Adam A Butchy, Yaniv Tivon, Victor So, Michael Kvorjak, Avani B Parikh, Eric L Adams, Natasa Miskov-Zivanov, Olivera J Finn, Alexander Deiters, Jason Lohmueller
Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting. Nature communications 14 (1) (2023)